International Life Sciences Review: Issue 8

February 2018

Welcome to the latest issue of our International Life Sciences Review, produced by our life sciences lawyers in the US, Europe and Asia and covering some of the most critical developments in the pharmaceutical and medical technology sectors in the last month. If you have questions on any of these topics, please contact please contact Paul Ranson.

In this issue, we cover updates relating to:

  • EU Orphan Medicines
  • EU Spcs And The Research Exemption
  • EU Spcs And Medical Devices
  • French Competition Enquiry
  • Netherlands Compulsory License Proposal
  • Managing Brexit
  • EU And US Medical Devices Regulation
  • EU Advanced Therapy Medicinal Products
  • Changes in US/EU Inspection Practice
  • Tough New Draft FDA Homeopathic Guidance
  • Relevance of Foreign Laws in US Anti-Trust
  • China – Unfair Competition and Bribery

Read the eighth issue of the International Life Sciences Review >>